Differential effect of insulin treatment on decreased levels of beta-defensins and Toll-like receptors in diabetic rats

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 796-802

  Froy, Oren ^a   Hananel, Amit ^a   Chapnik, Nava ^a   Madar, Zecharia ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Brain; Defensins; Diabetes; Kidney; Liver; Lung; Toll like receptors

Indexed keywords

BETA DEFENSIN; INSULIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; INSULIN DEFICIENCY; INSULIN TREATMENT; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT INFECTION; STREPTOZOCIN DIABETES;

ANIMALS; BETA-DEFENSINS; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; KIDNEY; LIVER; LUNG; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 33748770608     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.04.009     Document Type: Article

References (40)

1. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., and Ouellette A. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1 (2000) 113-118
2. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., and Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298 (2002) 1025-1029
3. Blankenhorn E.P., Rodemich L., Martin-Fernandez C., Leif J., Greiner D.L., and Mordes J.P. The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection. Diabetes 54 (2005) 1233-1237
4. Chavakis T., Bierhaus A., and Nawroth P.P. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 6 (2004) 1219-1225
5. Com E., Bourgeon F., Evrard B., Ganz T., Colleu D., Jegou B., and Pineau C. Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biol. Reprod. 68 (2003) 95-104
6. Cook D.N., Pisetsky D.S., and Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5 (2004) 975-979
7. Duits L.A., Ravensbergen B., Rademaker M., Hiemstra P.S., and Nibbering P.H. Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106 (2002) 517-525
8. Froy O., and Gurevitz M. Membrane potential modulators: a thread of scarlet from plants to humans. FASEB J. 12 (1998) 1793-1796
9. Froy O., Chang D.C., and Reppert S.M. Redox potential: differential roles in dCRY and mCRY1 functions. Curr. Biol. 12 (2002) 147-152
10. Froy O., and Gurevitz M. Arthropod and mollusk defensins-evolution by exon-shuffling. Trends Genet. 19 (2003) 684-687
11. Froy O., Gotter A.L., Casselman A.L., and Reppert S.M. Illuminating the circadian clock in monarch butterfly migration. Science 300 (2003) 1303-1305
12. Froy O., and Gurevitz M. Arthropod defensins illuminate the divergence of scorpion neurotoxins. J. Pept. Sci. 10 (2004) 714-718
13. Froy O., Hananel A., Chapnik N., and Madar Z. Differential expression of rat β-defensins. IUBMB Life 57 (2005) 41-43
14. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signaling pathways. Curr. Microbiol. 7 (2005) 1387-1397
15. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
16. Hiratsuka T., Nakazato M., Date Y., Mukae H., and Matsukura S. Nucleotide sequence and expression of rat beta-defensin-1: its significance in diabetic rodent models. Nephron 88 (2001) 65-70
17. Jia H.P., Mills J.N., Barahmand-Pour F., Nishimura D., Mallampali R.K., Wang G., Wiles K., Tack B.F., Bevins C.L., and McCray Jr. P.B. Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins. Infect. Immun. 67 (1999) 4827-4833
18. Kolek M.J., Carlquist J.F., Muhlestein J.B., Whiting B.M., Horne B.D., Bair T.L., and Anderson J.L. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am. Heart J. 148 (2004) 1034-1040
19. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., Odermatt B., Conrad C., Ittner L.M., Bauer S., Luther S.A., Uematsu S., Akira S., Hengartner H., and Zinkernagel R.M. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11 (2005) 138-145
20. Lehrer R.I., and Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 14 (2002) 96-102
21. Libal-Weksler Y., Gotlibovitz O., Stark A.H., and Madar Z. Diet and diabetic state modify glycogen synthase activity and expression in rat hepatocytes. J. Nutr. Biochem. 12 (2001) 458-464
22. Lin P.W., Simon P.O., Gewirtz A.T., Neish A.S., Ouellette A.J., Madara J.L., and Lencer W. Paneth cell cryptdins act in vitro as apical paracrine regulators of the innate inflammatory response. J. Biol. Chem. 279 (2004) 19902-19907
23. Morrison G., Kilanowski F., Davidson D., and Dorin J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70 (2002) 3053-3060
24. Page R.A., and Malik A.N. Elevated levels of beta defensin-1 mRNA in diabetic kidneys of GK rats. Biochem. Biophys. Res. Commun. 310 (2003) 513-521
25. Palladino M.A., Mallonga T.A., and Mishra M.S. Messenger RNA (mRNA) expression for the antimicrobial peptides beta-defensin-1 and beta-defensin-2 in the male rat reproductive tract: beta-defensin-1 mRNA in initial segment and caput epididymis is regulated by androgens and not bacterial lipopolysaccharides. Biol. Reprod. 68 (2003) 509-515
26. Park Y., Park S., Yoo E., Kim D., and Shin H. Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann. NY Acad. Sci. 1037 (2005) 170-174
27. Pirie F.J., Pegoraro R., Motala A.A., Rauff S., Rom L., Govender T., and Esterhuizen T.M. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 66 (2005) 125-130
28. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 (2005) 59-65
29. Raj P.A., and Dentino A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206 (2002) 9-18
30. Rasschaert J., Ladriere L., Urbain M., Dogusan Z., Katabua B., Sato S., Akira S., Gysemans C., Mathieu C., and Eizirik D.L. Toll-like receptor 3 and STAT-1 contribute for dsRNA + IFN-gamma-induced apoptosis in primary pancreatic beta-cells. J. Biol. Chem. 280 (2005) 33984-33991
31. Rudofsky G., Reismann P., Witte S., Humpert P.M., Isermann B., Chavakis T., Tafel J., Nosikov V.V., Hamann A., Nawroth P., and Bierhaus A. Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care 27 (2004) 179-183
32. Schagger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
33. Sheetz M.J., and King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288 (2002) 2579-2588
34. Singh P.K., Jia H.P., Wiles K., Hesselberth J., Liu L., Conway B.A., Greenberg E.P., Valore E.V., Welsh M.J., Ganz T., Tack B.F., and McCray P.B. Production of β-defensins by human airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14961-14966
35. Szewczyk B., and Kozloff L.M. A method for the efficient blotting of strongly basic proteins from sodium dodecyl sulfate-polyacrylamide gels to nitrocellulose. Anal. Biochem. 150 (1985) 403-407
36. Tomlinson D.R. Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42 (1999) 1271-1281
37. Wen L., Peng J., Li Z., and Wong F.S. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol. 172 (2004) 3173-3180
38. Woods S.C., Seeley R.J., Baskin D.G., and Schwartz M.W. Insulin and the blood-brain barrier. Curr. Pharm. Des. 9 (2003) 795-800
39. Yang D., Biragyn A., Kwak L.W., and Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 (2002) 291-296
40. Zhao C., Wang I., and Lehrer R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396 (1996) 319-322